Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 31.3B | 27.4B | 29.7B | 28.0B |
| Cost of revenue | 17.4B | 14.8B | 16.9B | 15.7B |
| Gross profit | 13.9B | 12.6B | 12.9B | 12.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 3.4B | 2.6B | 2.8B | 2.8B |
| Non operating interest income | ||||
| Income | 36M | 23M | 21M | 17M |
| Expense | 27M | 27M | 20M | 18M |
| Other income expense | — | — | — | — |
| Pretax income | 3.6B | 2.9B | 3.0B | 3.2B |
| Tax provision | 1.0B | 980M | 994M | 809M |
| Net income | 2.6B | 1.9B | 2.0B | 2.4B |
| Basic EPS | — | — | — | 27.8 |
| Diluted EPS | — | — | — | 27.8 |
| Basic average shares | — | — | — | 87.2M |
| Diluted average shares | — | — | — | 87.2M |
| EBITDA | 3.6B | 2.4B | 3.0B | 3.3B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -2M | -9M | -9M | -11M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |